Yahoo Finance report covering Aspen Aerogels Inc. (ASPN) market action, institutional positioning, and fundamental catalysts.
Why ASPN Stock dropped -6.31% Today — RQD Quant Desk Flash
Aspen Aerogels Inc. (ASPN) carries a Roarable Rating of E (Strong Sell) with 31/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.
🤖 Mara Quenwick • AI Quant Lead (Click for Instant Brief)
Is ASPN stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
▼
As of 2026-11-02, Aspen Aerogels Inc. (NYSE: ASPN) is rated E (Strong Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 31/100 at a spot price of $5.05 (-6.31% 1D, market cap $447.3M). Pillar breakdown: Fundamental Cash Engine 5/20, Institutional 13F & Options Flow 10/20, Executive Insider Alignment 5/20, FRED Macro Regime Fit 8/20, and SEC Balance-Sheet Forensics 3/20. Across 1011 tracked Consumer Discretionary issuers, ASPN ranks #870 in composite RQD confidence.
🤖 Ellis Vennor • AI Peer & Flow Quant (Click for Instant Brief)
How does ASPN compare to ZKH and GRWG in the Consumer Discretionary sector?
▼
Within the Consumer Discretionary sector (RETAIL: Building Materials), ASPN carries a Roarable E (31/100 RQD), trailing P/E of N/A, gross margin of 17.0%, and ROIC of -35.0%. By comparison, ZKH (ZKH Group Limited each representing thirty-five (35) (Class A)) holds a D grade (46/100 RQD, P/E N/A, ROIC —, cap $241.6M) and GRWG (GrowGeneration Corp.) posts a E grade (28/100 RQD, P/E N/A, ROIC -30.1%, cap $88.4M). Among the 5-stock peer group, BCC leads on earnings multiple (20.4x) while BCC leads on capital efficiency (7.1% ROIC).
🤖 Gideon Ashmere • AI SEC 10-K Forensics (Click for Instant Brief)
What are the biggest fundamental strengths and SEC risk factors for ASPN?
▼
Per ASPN's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001145986), Aspen Aerogels Inc. generated $271.1M in revenue (-40.1% YoY), -$389.6M in net income, and -$4.6M in free cash flow against $406.7M in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Consumer Discretionary with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.
Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer
20D Institutional Volume Accumulation (±10.3% realized swing band)
FRED Regime × Technicals: 44% of 52W Range • RSI-14 at 50.4 (NEUTRAL RANGE)
Dilution Drag (+2.48% YoY Shares) & executive Form 4 sales trim 16 pts from alignment
⚔️ Adversarial Opposing Case: What Could Spark a ASPN Turnaround Squeeze
While ASPN currently carries a cautious 31/100 (E) rating due to Insider Conviction & Share Dilution (4/20), shorts face asymmetric squeeze risk if free cash flow inflects or management executes accretive buybacks.
Established market leader in Consumer Discretionary with deep daily trading liquidity.
Options & Short-Covering Gamma: Reclaiming the 50-day SMA ($5.25) and Max Pain ($5.30) forces dealer call-delta covering toward $8.99.
Forensic Repair Trigger: Halting share dilution (Dilution Drag (+2.48% YoY Shares)) or retiring high-cost debt immediately upgrades the SEC 10-K Forensic pillar.
Why ASPN Stock dropped -6.31% Today — RQD Quant Desk Flash
Aspen Aerogels Inc. (ASPN) dropped -6.31% to $5.05, trading at 44% of its 52-week range ($2.3 – $8.56). Stretched risk/reward at current multiples (-35% return on capital) under elevated 10-year interest-rate pressure.
- ▸Technical Tape: Trading at 44% of its 52-week range ($2.3 – $8.56) with RSI-14 at 50.4 (NEUTRAL RANGE).
- ▸Volatility Profile: Historical 20-day realized swing band of ±10.3% around $5.05 (no active unusual options sweep snapshot on file).
- ▸Fundamental Anchor: Roarable E (Strong Sell) backed by 17% gross margin and $0 annual free cash flow.
Simply Wall St report covering Aspen Aerogels Inc. (ASPN) market action, institutional positioning, and fundamental catalysts.
Benzinga report covering Aspen Aerogels Inc. (ASPN) market action, institutional positioning, and fundamental catalysts.
TradingView report covering Aspen Aerogels Inc. (ASPN) market action, institutional positioning, and fundamental catalysts.
Stock Titan report covering Aspen Aerogels Inc. (ASPN) market action, institutional positioning, and fundamental catalysts.
Yahoo Finance report covering Aspen Aerogels Inc. (ASPN) market action, institutional positioning, and fundamental catalysts.
MarketBeat report covering Aspen Aerogels Inc. (ASPN) market action, institutional positioning, and fundamental catalysts.
Simply Wall St report covering Aspen Aerogels Inc. (ASPN) market action, institutional positioning, and fundamental catalysts.
Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring ASPN)
- ✓Walkthrough of ASPN's RQD Radar, SEC cash-conversion gap & downside invalidation levels
- ✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
- ✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks
ASPN Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
vs. -40.1% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
No active Ellis Vennor swing setup published on ASPN today. View full Setup Ledger →
No direct multi-tier Butterfly edges indexed yet for ASPN. Explore sector supply chains on /butterfly.
📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (ASPN)
1. Head-to-Head Consumer Discretionary Peer Comparison (ASPN vs. ZKH, GRWG, BCC, SMJF)
Industry: RETAIL: Building Materials (17 Tracked Issuers)Across 1011 tracked Consumer Discretionary securities in the Roarable RQD universe, Aspen Aerogels Inc. (ASPN) ranks #870 by composite RQD confidence (31/100, grade E) and #598 by equity capitalization ($447.3M). Within this direct 5-issuer industry benchmark cohort, BCC leads on earnings valuation at 20.4x trailing P/E, while BCC leads on capital efficiency and profitability with 7.1% ROIC and — gross margin. BCC currently holds the highest overall quantitative score in the immediate peer group at 52/100 (D+) compared with ASPN at 31/100 (E).
| Ticker / Company | Roarable Grade | RQD Score | Trailing P/E | Gross Margin | ROIC | 1D Change | Market Cap | Head-to-Head |
|---|---|---|---|---|---|---|---|---|
| ASPN
ACTIVE
Aspen Aerogels Inc. | E | 31/100 | — | 17.0% | -35.0% | -6.31% | $447.3M | Benchmark Subject |
| ZKH ZKH Group Limited each representing thirty-five (35) (Class A) | D | 46/100 | — | — | — | +7.90% | $241.6M | /zkh-vs-aspn → |
| GRWG GrowGeneration Corp. | E | 28/100 | — | 26.8% | -30.1% | 0.00% | $88.4M | /grwg-vs-aspn → |
| BCC Boise Cascade L.L.C. | D+ | 52/100 | 20.4x | — | 7.1% | +1.26% | $2.72B | /bcc-vs-aspn → |
| SMJF SMJ International Holdings Inc. (Class A) | E | 29/100 | — | 34.6% | — | +0.65% | $42.7M | /smjf-vs-aspn → |
2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)
SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0001145986In its most recent audited fiscal period (FY2025, filed 2025-12-31), Aspen Aerogels Inc. (ASPN) reported GAAP revenue of $271.1M (-40.1% vs. FY2024 revenue of $452.7M , and +13.6% cumulative change since FY2023) , GAAP net income of -$389.6M, operating cash flow of $32.9M, and free cash flow of -$4.6M (+88.8% YoY). On the balance sheet, ASPN closed FY2025 with $406.7M in total assets against $0 in total debt (Altman Z-Score: 0.20, Piotroski F-Score: 3/9).
| Fiscal Period | Filing Date | Revenue | Net Income | Operating Cash Flow | Free Cash Flow | Total Assets | Total Debt |
|---|---|---|---|---|---|---|---|
| FY2025 (FY) | 2025-12-31 | $271.1M | -$389.6M | $32.9M | -$4.6M | $406.7M | — |
| FY2024 (FY) | 2024-12-31 | $452.7M | $13.4M | $45.5M | -$40.7M | $895.1M | — |
| FY2023 (FY) | 2023-12-31 | $238.7M | -$45.8M | -$42.6M | -$42.6M | — | — |
3. ASPN Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)
✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLEDIs ASPN stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
As of 2026-11-02, Aspen Aerogels Inc. (NYSE: ASPN) is rated E (Strong Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 31/100 at a spot price of $5.05 (-6.31% 1D, market cap $447.3M). Pillar breakdown: Fundamental Cash Engine 5/20, Institutional 13F & Options Flow 10/20, Executive Insider Alignment 5/20, FRED Macro Regime Fit 8/20, and SEC Balance-Sheet Forensics 3/20. Across 1011 tracked Consumer Discretionary issuers, ASPN ranks #870 in composite RQD confidence.
How does ASPN compare to ZKH and GRWG in the Consumer Discretionary sector?
Within the Consumer Discretionary sector (RETAIL: Building Materials), ASPN carries a Roarable E (31/100 RQD), trailing P/E of N/A, gross margin of 17.0%, and ROIC of -35.0%. By comparison, ZKH (ZKH Group Limited each representing thirty-five (35) (Class A)) holds a D grade (46/100 RQD, P/E N/A, ROIC —, cap $241.6M) and GRWG (GrowGeneration Corp.) posts a E grade (28/100 RQD, P/E N/A, ROIC -30.1%, cap $88.4M). Among the 5-stock peer group, BCC leads on earnings multiple (20.4x) while BCC leads on capital efficiency (7.1% ROIC).
What are the biggest fundamental strengths and SEC risk factors for ASPN?
Per ASPN's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001145986), Aspen Aerogels Inc. generated $271.1M in revenue (-40.1% YoY), -$389.6M in net income, and -$4.6M in free cash flow against $406.7M in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Consumer Discretionary with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.
Where is ASPN trading relative to its 50-day, 200-day, and 52-week technical levels?
ASPN last traded at $5.05 (-6.31% on volume of 1,182,061 shares), positioning the stock -3.81% below its 50-day simple moving average ($5.25) and +7.91% above its 200-day simple moving average ($4.68). Across its 52-week range of $2.30 to $8.56, ASPN sits at the 43.9% percentile with a 14-day RSI of 50.4 (NEUTRAL RANGE) and an implied next-earnings move of ±10.3% ($4.53 to $5.57).
ASPN Investor FAQ & Complete 8-Part Research Index
100% OPEN ACCESS • SEC EDGAR × CBOE × FREDWhy is ASPN stock moving today?
Why ASPN Stock dropped -6.31% Today — RQD Quant Desk Flash. Stretched risk/reward at current multiples (-35% return on capital) under elevated 10-year interest-rate pressure.
ASPN — Aspen Aerogels Inc.: What the Facts Mean to a Prospective Investor
Roarable Rating Brief: What This Means to a Prospective Investor
Per the Roarable RQD rating, ASPN scores 31 out of a possible 100, earning a letter grade of E and the verdict "Roarable Strong Sell — Forensic Risk / Avoid." Across the five pillars:
- Fundamental Cash Engine (5 / 20): Per the Roarable RQD rating, ROIC is -35% and FCF yield is -1.02%. This is the weakest pillar and signals that the business is not currently generating returns on capital or free cash for shareholders. The investor implication is that any valuation case must rest on a future turnaround rather than present cash generation.
- Whale 13F Flow (10 / 20): Per the Roarable RQD rating, this pillar reflects institutional accumulation and options positioning. The score is moderate-low, suggesting institutional interest is present but not strongly directional.
- Insider Conviction (3 / 20): Per the Roarable RQD rating, SEC Form 4 and Congressional PTR cluster flow scores very low. For a prospective investor, the absence of meaningful insider conviction removes one common signal of management confidence.
- Macro Regime Fit (8 / 20): Per the Roarable RQD rating, Beta is 1.0 and sector sensitivity is noted. The stock tracks broad market moves without a demonstrated defensive or regime-specific advantage.
- Forensic Balance Sheet (5 / 20): Per the Roarable RQD rating, Altman Z is 0.2, Piotroski F is 3/9, and Debt/Equity is 0.5. The Altman Z reading is in the range that the rating's methodology treats as distress-associated, which is the central forensic concern.
Taken together, the investor takeaway is that upside drivers are limited to a possible operating turnaround, institutional accumulation, and the sharp prior range, while the principal tradeoffs are negative margins, negative ROIC, weak balance-sheet forensics, and absent insider conviction. The rating itself frames the stock as avoid-oriented. This is educational analysis, not personalized advice.
Financial Trend
| Period | Revenue | Operating Income | Net Income | EPS | FCF | Cash | Debt |
|---|---|---|---|---|---|---|---|
| FY 2025 | $271.1M | $-378.2M | $-389.6M | N/A | $-4.6M | $156.9M | N/A |
| FY 2024 | $452.7M | $54.5M | $13.4M | N/A | $-40.7M | $220.9M | N/A |
| FY 2023 | $238.7M | $-49.2M | $-45.8M | N/A | $-42.6M | N/A | N/A |
Per the SEC financials, FY 2025 revenue fell from $452.7M to $271.1M, and operating income swung from $54.5M to $-378.2M. Per the market data, gross margin is 17%, operating margin is -60%, and net margin is -60%, with ROIC at -35%. Per the Roarable RQD rating, the Altman Z-Score is 0.2 and the Piotroski F-Score is 3/9. Cash declined from $220.9M to $156.9M across the last two reported years, and debt is listed as N/A in the filings, with Debt/Equity at 0.5 per the RQD rating.
Butterfly Effect: 2nd-Order Supply-Chain & Sector Ripples
Per the Butterfly Supply-Chain Graph, no upstream or downstream supply-chain dependencies, butterfly links, or proprietary sector signals are mapped for ASPN. Sector correlations and 2nd-order bottleneck analysis therefore cannot be drawn from the source data. The investor should note that the graph's absence of mapped links means ripple effects from suppliers, customers, or peers are not quantified here.
Open Questions
- What drove the FY 2025 revenue decline from $452.7M to $271.1M, and is it cyclical or structural?
- Why is debt reported as N/A in the filings while Debt/Equity is 0.5 per the RQD rating?
- What is the Q3 2026 earnings release date, and what are management's guidance expectations?
- What is the basis for the reported $-389.6M FY 2025 net loss relative to the $-378.2M operating loss, and what non-operating items contributed?
- What do the institutional and passive holders (including the AIGH Capital Management stake) indicate about positioning, given the absence of holder detail in the source data?
ASPN Live News Feed, Press Releases & Catalyst Wire
Real-time company headlines, analyst actions, and sector developments for Aspen Aerogels Inc. (ASPN) • Click "Debate This Headline" to argue it in the Roar Pit below
Yahoo Finance report covering Aspen Aerogels Inc. (ASPN) market action, institutional positioning, and fundamental catalysts.
Simply Wall St report covering Aspen Aerogels Inc. (ASPN) market action, institutional positioning, and fundamental catalysts.
Benzinga report covering Aspen Aerogels Inc. (ASPN) market action, institutional positioning, and fundamental catalysts.
TradingView report covering Aspen Aerogels Inc. (ASPN) market action, institutional positioning, and fundamental catalysts.
Stock Titan report covering Aspen Aerogels Inc. (ASPN) market action, institutional positioning, and fundamental catalysts.
Yahoo Finance report covering Aspen Aerogels Inc. (ASPN) market action, institutional positioning, and fundamental catalysts.
MarketBeat report covering Aspen Aerogels Inc. (ASPN) market action, institutional positioning, and fundamental catalysts.
Simply Wall St report covering Aspen Aerogels Inc. (ASPN) market action, institutional positioning, and fundamental catalysts.
ASPN Bull vs. Bear Conversation Board — What's Your Call at $5.05?
🔥 Official Bull vs. Bear Debate: Is ASPN (E • RQD 31/100) a Buy at $5.39?
Welcome to the ASPN (Aspen Aerogels Inc.) Roar Pit. Current RQD Composite is 31/100 (Roarable Strong Sell — Forensic Risk / Avoid) in RETAIL: Building Materials. Bulls point to operating leverage and sector positioning, while bears focus on macro rate sensitivity and margin execution. Pick your side (🐂 Bull or 🐻 Bear) and drop your price target below.
Pump the brakes on ASPN — check the valuation vs. margin headwinds
Everyone in here is repeating the bull case on ASPN, but look at what you are paying: current EV/EBITDA multiples with 17.0% gross margins. Unless Aspen Aerogels Inc. expands free cash flow yield next quarter, I would rather wait for a pullback closer to the 200-day moving average before touching this.
ASPN cash flow & RQD setup is being underpriced by the Street here
Looking at the 5-pillar RQD breakdown on ASPN, the market is fixating on short-term headline noise in RETAIL: Building Materials and ignoring the balance sheet and cash flow trajectory. At $5.39 (52-wk range $2.30 - $8.56), any beat on forward guidance forces shorts and underweight funds to chase.